Cargando…
RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
BACKGROUND: Human papillomavirus (HPV) DNA testing plays a main role in the management of cervical cancer, however to improve the specificity in cervical screening, there is a need to develop and validate different approaches that can identify women at risk for progressive disease. Nowadays, mRNA ex...
Autores principales: | Fontecha, Nerea, Nieto, Maria Carmen, Andía, Daniel, Cisterna, Ramón, Basaras, Miren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345170/ https://www.ncbi.nlm.nih.gov/pubmed/28279212 http://dx.doi.org/10.1186/s12985-017-0720-x |
Ejemplares similares
-
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
por: Fontecha, Nerea, et al.
Publicado: (2016) -
Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain
por: Arroyo, Sara L, et al.
Publicado: (2012) -
Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain
por: Arroyo, L. Sara, et al.
Publicado: (2016) -
REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022) -
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
por: Zheng, Yunji, et al.
Publicado: (2022)